Artificial Intelligence and Its Effect on Dermatologists’ Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study
Journal of Medical Internet Research, vol. 22, pp. e18091
Abstract
BACKGROUND: Early detection of melanoma can be lifesaving but this remains a challenge. Recent diagnostic studies have revealed the superiority of artificial intelligence (AI) in classifying dermoscopic images of melanoma and nevi, concluding that these algorithms should assist a dermatologist's diagnoses. OBJECTIVE: The aim of this study was to investigate whether AI support improves the accuracy and overall diagnostic performance of dermatologists in the dichotomous image-based discrimination between melanoma and nevus. METHODS: Twelve board-certified dermatologists were presented disjoint sets of 100 unique dermoscopic images of melanomas and nevi (total of 1200 unique images), and they had to classify the images based on personal experience alone (part I) and with the support of a trained convolutional neural network (CNN, part II). Additionally, dermatologists were asked to rate their confidence in their final decision for each image. RESULTS: While the mean specificity of the dermatologists based on personal experience alone remained almost unchanged (70.6% vs 72.4%; P=.54) with AI support, the mean sensitivity and mean accuracy increased significantly (59.4% vs 74.6%; P=.003 and 65.0% vs 73.6%; P=.002, respectively) with AI support. Out of the 10% (10/94; 95% CI 8.4%-11.8%) of cases where dermatologists were correct and AI was incorrect, dermatologists on average changed to the incorrect answer for 39% (4/10; 95% CI 23.2%-55.6%) of cases. When dermatologists were incorrect and AI was correct (25/94, 27%; 95% CI 24.0%-30.1%), dermatologists changed their answers to the correct answer for 46% (11/25; 95% CI 33.1%-58.4%) of cases. Additionally, the dermatologists' average confidence in their decisions increased when the CNN confirmed their decision and decreased when the CNN disagreed, even when the dermatologists were correct. Reported values are based on the mean of all participants. Whenever absolute values are shown, the denominator and numerator are approximations as every dermatologist ended up rating a varying number of images due to a quality control step. CONCLUSIONS: The findings of our study show that AI support can improve the overall accuracy of the dermatologists in the dichotomous image-based discrimination between melanoma and nevus. This supports the argument for AI-based tools to aid clinicians in skin lesion classification and provides a rationale for studies of such classifiers in real-life settings, wherein clinicians can integrate additional information such as patient age and medical history into their decisions.
Authors 20
-
German Cancer Research Center · National Center for Tumor Diseases
Affiliation as printed
Digital Biomarkers for Oncology Group (DBO), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany
-
German Cancer Research Center · Heidelberg University · University Medical Centre Mannheim
Affiliation as printed
Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Heidelberg, Germany
Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany
-
German Cancer Research Center · National Center for Tumor Diseases
Affiliation as printed
Digital Biomarkers for Oncology Group (DBO), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany
-
Christian-Albrechts-Universität zu Kiel
Affiliation as printed
Department of Dermatology, University Hospital Kiel, University of Kiel, Kiel, Germany
-
LMU Klinikum · Ludwig-Maximilians-Universität München
Affiliation as printed
Department of Dermatology, University Hospital Munich (LMU), Munich, Germany
-
Essen University Hospital · University of Duisburg-Essen
Affiliation as printed
Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
-
University Hospital Regensburg
Affiliation as printed
Department of Dermatology, University Hospital Regensburg, Regensburg, Germany
-
University of Würzburg · Universitätsklinikum Würzburg
Affiliation as printed
Department of Dermatology, University Hospital Würzburg, University of Würzburg, Würzburg, Germany
-
Affiliation as printed
Department of Dermatology, University Hospital Erlangen, University of Erlangen, Erlangen, Germany
-
Essen University Hospital · University of Duisburg-Essen
Affiliation as printed
Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
-
LMU Klinikum · Ludwig-Maximilians-Universität München
Affiliation as printed
Department of Dermatology, University Hospital Munich (LMU), Munich, Germany
-
Affiliation as printed
Department of Dermatology, University Hospital Cologne, Cologne, Germany
-
Affiliation as printed
Department of Dermatology, University Hospital Aachen, Aachen, Germany
-
LMU Klinikum · Ludwig-Maximilians-Universität München
Affiliation as printed
Department of Dermatology, University Hospital Munich (LMU), Munich, Germany
-
German Cancer Research Center · National Center for Tumor Diseases
Affiliation as printed
Digital Biomarkers for Oncology Group (DBO), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany
-
German Cancer Research Center · National Center for Tumor Diseases
Affiliation as printed
Digital Biomarkers for Oncology Group (DBO), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany
-
Christian-Albrechts-Universität zu Kiel
Affiliation as printed
Department of Dermatology, University Hospital Kiel, University of Kiel, Kiel, Germany
-
Berlin Institute of Health at Charité - Universitätsmedizin Berlin · Charité - Universitätsmedizin Berlin
Affiliation as printed
Department of Clinical-Translational Sciences, Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany
-
German Cancer Research Center · National Center for Tumor Diseases
Affiliation as printed
National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany
-
Titus Josef Brinker corresponding
German Cancer Research Center · National Center for Tumor Diseases
Affiliation as printed
Digital Biomarkers for Oncology Group (DBO), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany
Cited by 91 stored of 91
No patents citing this paper on Lens.org (checked 2026-10-06).